Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Repertoire Immune Medicines

Repertoire Immune Medicines
2015 FOUNDED
PRIVATE STATUS
101-200 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
2 INVESTORS
Description

Developer of a biotechnology system created to unleash the human immune system. The company is conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15 to prevent, treat or cure cancer, autoimmune conditions and infectious diseases, hence enabling doctors to treat various patients with effective solutions.

Formerly Known As
Torque, Torque Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Primary Office
  • 26 Landsdowne Street
  • Cambridge, MA 02139
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Repertoire Immune Medicines’s full profile, request a free trial.

Repertoire Immune Medicines Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 25-Mar-2020 000.00 Completed Clinical Trials - General
2. Early Stage VC (Series B) 15-Jul-2019 000.00 000.00 00000 Completed Startup
1. Early Stage VC (Series A) 18-Apr-2018 $46M $46M 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Repertoire Immune Medicines Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00 00 00 00 00.000
Series A1 00,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series A 15,776,666 $0.000100 $1 $1 1x $1 23.28%
To view this company’s complete Cap Table, request access »

Repertoire Immune Medicines Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
T1D Fund Venture Capital Minority 000 0000 000000 0
Flagship Pioneering Venture Capital Minority 000 0000 000000 0

Repertoire Immune Medicines Executive Team (10)

Name Title Board
Seat
Contact
Info
John Cox Chief Executive Officer & Board Member
Sok Cheng Soh Chief Financial Officer
Jennifer Camacho JD Chief Legal Officer
Thomas Andresen Ph.D Co-Founder and Chief Scientific Officer
Stephen Hodi MD Scientific Advisory Board Member

2 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

Repertoire Immune Medicines Board Members (11)

Name Representing Role Since Contact
Info
Douglas Cole MD Flagship Pioneering Board Member 000 0000
Douglas Lauffenburger Ph.D Self Board Member 000 0000
John Cox Repertoire Immune Medicines Chief Executive Officer & Board Member 000 0000
John Dineen Self Board Member 000 0000
John Hohneker MD Self Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 11 board members. Get the full list »